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Acute ﬁbrinous and organizing pneumonia (AFOP) is a very rare pathological entity of lung injury
characterized by intra-alveolar ﬁbrin balls.
Hemeoxygenase (HO) -1 is a cytoprotective enzyme against oxidative stress and inﬂammation. It is
known to be expressed in the alveolar macrophages in the healthy adults and overexpressed in other
various lung cells of the lung injury patients.
We experienced two cases of subacute form AFOP for these 10 years and reviewed clinico-pathological
characteristics. The average age was 62 years old and both were male. The etiology of both cases was
idiopathic. The average PaO2/FIO2 ratio was 274.5 ± 84.1. The average levels of C-reactive protein and
surfactant protein - A of the serumwere elevated to 19.8 ± 6.3 mg/dL and 67.6 ± 15.8 ng/mL, respectively.
Serum sialylated carbohydrate antigen levels were normal in both cases. The characteristic radiographic
ﬁndings were bilateral consolidations and ground glass opacities. Lung biopsy specimens revealed ﬁbrin
balls and alveolitis with abundant cellular HO-1 expression. Steroid response was excellent and the
pulmonary involvements absolutely disappeared for about 3 months.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Acute ﬁbrinous and organizing pneumonia (AFOP), ﬁrst
described by Beasley, is a very rare histological entity, which is
characterized by intra-alveolar deposit of ﬁbrin forming ﬁbrin balls
and organizing pneumonia (OP) with patchy distribution without
hyaline membrane, eosinophilic inﬁltrations, extensive abscess
formation and granulomatous inﬂammation [1]. The histological
pattern of AFOP is known to be the variant of diffuse alveolar
damage (DAD) and OP. AFOP may be idiopathic in nature or asso-
ciated with infection (Haemophilus inﬂuenza, Pneumocystis jiroveci
and Chlamydia Pneumoniae and HIV infection), connective tissue
disorders (systemic lupus erythematosus and undifferentiated
connective tissue disease), drug exposure (avacavir, amiodarone
and decitabine), and hematological malignancies (myelodysplasticr, Yokohama City University
ama City 232-0024, Japan.
inkai).
Ltd. This is an open access article usyndrome and lymphoma). Beasley et al. described two distinct
patterns of disease progression: acute form with rapid progression
to death or subacute formwith recovery [1]. In the literature review
of 29 AFOP cases, 19 cases were subacute form and acute form was
more critical than subacute form [2]. Beasley et al. noted that 9 out
of 17 AFOP cases were dead of the disease and the time from the
presentation of symptoms to the death was 6e36 days (average 29
days).
HO-1, 32 kDa heat shock protein, is a cytoprotective enzyme
playing a central role in the defense against oxidative stress and
inﬂammation in the lung catalyzing the degradation of heme
into biliverdin, iron, and carbon monoxide [3]. In the healthy lung,
HO-1 is expressed mainly in the alveolar macrophages [4]. On the
injuried lung, HO-1 is known to limit the disease progression
potentially by the HO-1 overexpression in the alveolar macro-
phages, epithelial cells, endothelial cells and ﬁbroblasts, reﬂecting
pulmonary cellular protective reaction [5].
We experienced the rare two cases of subacute form AFOP and
examined these clinical characteristics (etiology, serum biomarkersnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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drate antigen (KL-6) that were widely used as the biomarkers for
interstitial lung diseases (ILD), radiographic ﬁndings and treatment
outcome) (case 2 has been already published [6]). Moreover,
we assessed the pathophysiology of these AFOP cases using
hematoxylin-eosin and HO-1 immunohistichemical staining using
monoclonal anti-HO-1 antibody (abcam, Tokyo, Japan; dilution
1:100). This study were approved by the institutional review board
of National Defense Medical College.
Case reports
Case 1
A 70-year-old man had complained of fever and dry cough for
one week. The chest radiograph at his ﬁrst visit showed right
upper lobe opacity. He developed dyspnea and was admitted to our
hospital one week later with tachypnea and fever. Fine crackles
were heard in the right chest. White blood cell counts (WBC) was
18700/mL (normal: 4000e8000/mL), C-reactive protein (CRP) was
24.2 mg/dL (normal: &0.3 mg/dL). Brain natriuretic peptide,
antineutrophil cytoplasmic antibodies (ANCA) and antinuclear
antibody (ANA) were normal. Urine antigen testing for Legionella
and Streptococcus pneumoniae was negative. Blood gas analysis
(BGA) showed hypoxemia with pH 7.43, PaCO2 34 mmHg and PaO2
62 mmHg with oxygen supplementation (2 L) by nasal cannula.
High-resolution computed tomography (HRCT) showed ground
glass opacities (GGO) in the subpleural upper lobe. His symptoms
progressed over a week despite oxygen and antibiotics and repeat
HRCT showed air space consolidation with GGO in the right upper
and middle lobes with some GGO in the left lung as well (Fig. 1A).
The bronchoalveolar lavage ﬂuid (BALF) had a total cell count of
8.4  105/mL, with 9% macrophages, 16% lymphocytes, 1% eosino-
phils, 74% neutrophils and CD4/8 ratio of 1.93. Cytomegalovirus and
Pneumocystis jeroveci were negative by polymerase chain reaction
(PCR). Transbronchial lung biopsy (TBLB) specimens showed
numerous ﬁbrin balls and hyperplasia of type II pneumocytes.
Eosinophils, hyaline membranes, and hemosiderin-laden macro-
phages were absent. Immunohistochemistry of biposy specimensFig. 1. High resolution computed tomography revealed air space consolidation intermingled
bilateral patchy consolidation and diffuse small nodules (B: case 2).using anti-HO-1 antibody conﬁrmed increased HO-1 in the mac-
rophages within ﬁbrin balls and alveolar walls around ﬁbrin
balls (Fig. 2A). Methylpredonisolone pulse therapy was given,
1000 mg/day for 3 days, followed by oral prednisolone (0.5 mg/kg).
After two weeks, his symptoms and chest radiograph dramatically
improved and pulmonary involvements absolutely disappeared
after about 3.7 months without relapse.
Case 2 [6].
A 55-year-old man had visited a hospital for chronic gromer-
ulonephritis and had been on dialysis for ﬁfteen years. He had
complained of cough and dyspnea for two weeks. And the initial
chest radiograph revealed a localized nodular lesion. After 3 weeks,
the opacities getting worse rapidly and HRCT revealed bilateral
patchy consolidation and diffuse small nodules (Fig. 1B). WBC
was 4200/mL, CRP was 15.3 mg/dL. ANCA and ANA were normal.
Urine antigen testing for Legionella and S. pneumoniaewas negative.
BGA showed hypoxemia with pH 7.411, PaCO2 34.0 mmHg and
PaO2 70.1 mmHg (room air). The BALF had a total cell count of
3.7  105/mL, with 93% macrophages, 5% lymphocytes, 2% neutro-
phils and CD4/8 ratio of 1.94. Cytomegalovirus and P. jeroveci were
negative by PCR. Surgical lung biopsy (SLB) specimens revealed
numerous ﬁbrin balls and organization with type II pneumocytes
hyperplasia without the presence of hyaline membranes, eosino-
philic inﬁltrations and granulomas (Fig. 2B). And HO-1 was over-
expressed in the macrophages within ﬁbrin balls and alveolar
epithelial cells. Methylpredonisolone pulse therapy was given,
1000 mg/day for 3days, followed by oral prednisolone (0.5 mg/kg).
Pulmonary involvements dramatically improved and almost
disappeared after 3 months.
Discussion
We experienced the rare two cases of subacute form AFOP for
these 10 years and reviewed these clinico-pathological character-
istics (Table 1).
The average age was 62.5 years old and both cases were male.
Lopez-Cuenca et al. reported in the review of literature of AFOP thatgroung glass opacities in the upper and middle lobes in the right lung (A: case 1) and
Fig. 2. Case 1 (A) was diagnosed by transbronchial lung biopsy and case 2 (B) was by surgical lung biopsy. These specimens revealed the numerous ﬁbrin balls, organizing loose
connective tissues and hyperplasia of type II pneumocytes. But the accumulation of eosinophils, the formation of hyaline membrane and hemosiderin-laden macrophages were
not visible (hematoxylin-eosin stain, original magniﬁcation  200). Immunohistochemical stain with anti-hemeoxygenase (HO) -1 antibody to the affected lung demonstrated HO-1
overexpression in the macrophages within ﬁbrin balls and type II pneumocytes around ﬁbrin balls (original magniﬁcation  200).
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(66%) [2]. There was no current smoker in our AFOP cases, but the
relationship between smoking status and the incidence of AFOP
was unclear. The probable etiology of our cases was idiopathic.
In the previous reports of AFOP, the most frequent etiology was also
idiopathic other than collagen vascular disorders, infection and
drug reaction. The average time of presentation of symptoms to
starting treatment was 3.4 weeks and all cases were subacute form.
Beasley et al., noted that the survival rate of acute form was worseTable 1
The clinico-pathological characteristics of our AFOP cases.
Characteristic Case 1
Age/Gender 70yrs/male
Smoking status Never smoker
Medical history None
Etiology Idiopathic
Time evolution 5 weeks
Diagnostic procedure Transbronchial lung biopsy
PaO2/FIO2 215
APACHE II 12
CRP (mg/dL) (<0.3) 24.2
LDH (IU/L) (<225) 209
SP-A (ng/mL) (<43.8) 56.4
SP-D (ng/mL) (<110) 34.4
KL-6 (U/mL) (<500) 343
The ﬁndings of computed tomography Bilateral air space consolidation and G
Pathological ﬁndings Numerous FBs with type II pneumocy
Distribution of Hemeoxygenase-1 FBs and alveolar walls
Treatment and outcome Steroid pulse, then taperd for 3 mont
Without relapse for 3.5 years
APACHE, Acute Physiology and Chronic Health Evaluation; CRP, C-reactive protein; LDH,
GGO, Ground Glass Opacity; FBs, ﬁbrin balls.than subacute form [1]. The diagnostic procedure of case 1 and 2
was TBLB, although the most frequent procedure was SLB because
of the non-speciﬁc reaction adjacent to lesions such as granuloma,
abscesses and neoplasm [7]. However, we believe that even if it
is impossible to perform SLB due to severe hypoxemia, AFOP should
be diagnosed under the careful evaluation of clinical and radio-
graphic information with small biopsy specimens. Actually, the
case of AFOP following hematopoietic stem cell transplantation














GO Bilateral patchy consolidation and diffuse small nodules
tes hyperplasia Numerous FBs and organization with type II
pneumocytes hyperplasia
Alveolar walls dominant
hs Steroid pulse, then tapered for 3 months
Without relapse for 9 years
lactate dehydrogenase; SP, sufactant protein; KL-6, sialylated carbohydrate antigen;
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average CRP levels were elevated to 19.8 mg/dL. In spite of sever
hypoxemia and inﬂammation, the average acute physiology and
chronic health evaluation II score was relatively low and not so
critical. We also evaluated serum SP-A, SP-D and KL-6 levels and
found that serum SP-A was elevated and serum KL-6 was normal in
all three cases. To our knowledge, there were no AFOP case reports
which were discussed about serum SP-A levels. According to the
report of Takahashi et al., serum SP-A levels elevated due to the
accelerated production by type II pneumocytes or destruction of the
epithelial-endothelium barrier [9]. And serum KL-6 levels are
considered to be associated with increased permeability of alveolar
capillary barrier [10] and the regeneration of type II pneumocytes
(induced by ﬁbroblast in vitro [11]) [12]. From these, it is suggested
that in AFOP patients, serum SP-A levels elevated due to the
accelerated production by type II pneumocytes hyperplasia but
serum KL-6 levels were normal due to the lack of ﬁbrosis or mild
destruction of epithelial-endothelium barrier. In case 1, serum SP-A
levels was normalized after steroid therapy (data not shown).
However, because serum SP-A is non-speciﬁc biomarker for patients
with ILD, we need to establish further prospective research whether
serum SP-A could become biomarker for patients with AFOP.
Beasley et al. noted that the most common radiographic ﬁnding
was bilateral patchy inﬁltrate [1]. The radiographic ﬁndings of
both two cases revealed bilateral consolidation which were typical
ﬁndings. When diagnosing of AFOP, we need to evaluate HRCT
ﬁndings with careful consideration, because it can be difﬁcult to
perform SLB under the critical respiratory failure.
AFOP has not any speciﬁc treatment. In case 1, steroid therapy
was initiated due to the lack of response of antibiotics. In both two
cases, steroid pulse therapy was given and then steroid was tapered
for 3 months. After the steroid administration, pulmonary in-
volvements absolutely disappeared for a few months. Perhaps,
despite of severe hypoxemia and inﬂammation, the steroid
response of subacute form AFOP is good due to the lack of ﬁbrosis
and maybe mild destruction of the epithelial-endothelium barrier.
Katzenstein and Beasley classiﬁed DAD, AFOP and COP into lung
injury pattern [7,13]. And the disease progression of DAD is the
most ﬂuminant. HO-1 is a stress-inducible protein, working as a
cytoprotective enzyme in the defense against oxidative stress and
inﬂammation in the lung by catalyzing the degradation of heme
into biliverdin, iron, and carbonmonoxide [3] and is known to limit
the progression of lung injury potentially [14]. We evaluated the
pulmonary cellular HO-1 expression of our AFOP, COP and DAD
cases (COP: 3 cases diagnosed by SLB, DAD: single autopsy case)
using the immunohistochemical staining with HO-1 and found
that in the AFOP lung, HO-1 was overexpressed mainly in the
macrophages within ﬁbrin balls and type II pneumocytes, while in
the healthy lung, HO-1 mainly expressed in the alveolar macro-
phages, and the pulmonary HO-1 expression was apparent from in
DAD lung to in COP lung in order (Supplementary data). So it
implies that the degree of HO-1 expression in the lungmight reﬂect
the severity of lung injury and the pulmonary cellular HO-1
overexpression might contribute to limit the progression of lung
injury potentially. Furthermore, in case 1, serum and BALF HO-1
levels on admission measured using enzyme-linked immunosor-
bent assay method were 4.1 ng/mL and 10.3 ng/mL, respectively
and decreased after two weeks to 1.2 ng/mL in serum and unde-
tectable level in BALF (for discussion e previously reported normal
range of serum HO-1 is 2.75 ± 0.22 ng/mL (Age: 71.6 ± 1.0 yr) [15]).
These suggested that serum and BALF HO-1 levels might reﬂect
pulmonary cellular HO-1 expression in patients with AFOP,however, we need further study about the relationship between
severity of lung injury and serum and BALF HO-1 levels.
In conclusion, we examined the clinico-pathological character-
istics of subacute form of AFOP cases. The steroid therapy might be
the main therapeutic option for subacute form AFOP. Also, we think
that the pulmonary overexpression of HO-1 might inﬂuence the
pathophysiology and clinical outcomes of subacute form AFOP.
This case reports have been presented in American Thoracic
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